Anne Vanlent

Insider Reports History

Entity
Individual
Location
C/O Barrier Therapeutics, Inc., 600 College Road East, Suite 3200, Princeton, NJ
Signature
/s/ Christopher Galletta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anne Vanlent:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Trevi Therapeutics, Inc. Director Nonstatutory Stock Option (right to buy) 30K Jun 13, 2024 Direct
APPLIED GENETIC TECHNOLOGIES CORP Director Stock Option (Right to Buy) 0 Nov 30, 2022 Direct

Insider Reports Filed by Anne Vanlent

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TRVI Trevi Therapeutics, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
TRVI Trevi Therapeutics, Inc. Jun 28, 2023 1 $0 4 Jun 30, 2023 Director
OBSV ObsEva SA Jan 1, 2023 0 $0 3 Jan 3, 2023 Director
AGTC APPLIED GENETIC TECHNOLOGIES CORP Nov 30, 2022 7 $0 4 Dec 1, 2022 Director
TRVI Trevi Therapeutics, Inc. Jun 23, 2022 1 $0 4/A Jul 1, 2022 Director
AGTC APPLIED GENETIC TECHNOLOGIES CORP Nov 30, 2021 1 $0 4 Dec 2, 2021 Director
TRVI Trevi Therapeutics, Inc. Jun 16, 2021 1 $0 4 Jun 17, 2021 Director